Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP...
-
Upload
alicia-newton -
Category
Documents
-
view
214 -
download
1
Transcript of Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP...
![Page 1: Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP Corporate Director Institutional Review Board Christiana Care.](https://reader034.fdocuments.in/reader034/viewer/2022042822/56649e4e5503460f94b44404/html5/thumbnails/1.jpg)
Compliance Issues for Medical Research
at Healthcare Systems
Jerry Castellano, Pharm.D., CIPCorporate Director
Institutional Review BoardChristiana Care Health System
![Page 2: Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP Corporate Director Institutional Review Board Christiana Care.](https://reader034.fdocuments.in/reader034/viewer/2022042822/56649e4e5503460f94b44404/html5/thumbnails/2.jpg)
![Page 3: Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP Corporate Director Institutional Review Board Christiana Care.](https://reader034.fdocuments.in/reader034/viewer/2022042822/56649e4e5503460f94b44404/html5/thumbnails/3.jpg)
Driving Forces for Compliance
• Institutions
• Accreditation Agencies & Oversight
• Federal Government - Agencies/Offices
• State and local Government
• Private Sector
• Research Participants and Public
![Page 4: Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP Corporate Director Institutional Review Board Christiana Care.](https://reader034.fdocuments.in/reader034/viewer/2022042822/56649e4e5503460f94b44404/html5/thumbnails/4.jpg)
The Government: Developing an Integrated ApproachHHS/OIG 2004 Strategic Workplan
• Examine role of IRB’s in overseeing clinical research involving children•Determine if Medicare payments to clinical trials were made in accordance with program specification•Determine if existing Medicare billing systems can accurately monitor the “appropriateness of these payments”•Conflict of Interest (COI) regulations
![Page 5: Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP Corporate Director Institutional Review Board Christiana Care.](https://reader034.fdocuments.in/reader034/viewer/2022042822/56649e4e5503460f94b44404/html5/thumbnails/5.jpg)
The Government: Developing an Integrated ApproachHHS/OIG 2004 Strategic Workplan
•Audit of NIH practices to ensure that grantees are complying with adverse event reporting and monitoring in clinical trial regulations.
•Grant auditing to ascertain that indirect and direct cost awarded funds are appropriately allocated to their respective cost definitions.
•Compliance with HIPAA regulations on safeguarding participant records with respect to maintaining confidentiality of personal medical records.
![Page 6: Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP Corporate Director Institutional Review Board Christiana Care.](https://reader034.fdocuments.in/reader034/viewer/2022042822/56649e4e5503460f94b44404/html5/thumbnails/6.jpg)
The Government: Developing an Integrated ApproachHHS/OIG 2004 Strategic Workplan
•Oversight of Intramural Clinical Trials (FDA)
– inventory of clinical trials
– develop quality control programs at each FDA center
– ensure research is conducted under appropriate regulatory scheme for product being tested
– initiating mandatory educational and certification program for all FDA clinical investigators on the scientific, regulatory and ethical issues regarding
clinical research
![Page 7: Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP Corporate Director Institutional Review Board Christiana Care.](https://reader034.fdocuments.in/reader034/viewer/2022042822/56649e4e5503460f94b44404/html5/thumbnails/7.jpg)
Health System Challenges
• Multiple sites of care
• Geography and proximity of sites
• Private Practice Medical/Dental Staff
• Workforce Size
• Effective Communication to stakeholders
• Limited Resources across continuum
![Page 8: Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP Corporate Director Institutional Review Board Christiana Care.](https://reader034.fdocuments.in/reader034/viewer/2022042822/56649e4e5503460f94b44404/html5/thumbnails/8.jpg)
Health System Challenges Accreditation Agencies & Oversight
• JCAHO• CLIA• OSHA• FAA• ICC• DOT
• Health System multi-specialty Accreditations
![Page 9: Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP Corporate Director Institutional Review Board Christiana Care.](https://reader034.fdocuments.in/reader034/viewer/2022042822/56649e4e5503460f94b44404/html5/thumbnails/9.jpg)
Health System Challenges Federal, State and Local Government
• Finance (Medicare, Medicaid, Third Party Insurers)
• OHRP• FDA• NIH• HIPAA• OIG• Boards of Professional Practice• IRS
![Page 10: Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP Corporate Director Institutional Review Board Christiana Care.](https://reader034.fdocuments.in/reader034/viewer/2022042822/56649e4e5503460f94b44404/html5/thumbnails/10.jpg)
Research Enterprise
IRB
AdministrativeStaff
CommunicationsSystem
InformationSystem
ComplianceOversight
QualityManagement
Adverse EventManagement
ConflictManagement
EducationPrograms
![Page 11: Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP Corporate Director Institutional Review Board Christiana Care.](https://reader034.fdocuments.in/reader034/viewer/2022042822/56649e4e5503460f94b44404/html5/thumbnails/11.jpg)
![Page 12: Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP Corporate Director Institutional Review Board Christiana Care.](https://reader034.fdocuments.in/reader034/viewer/2022042822/56649e4e5503460f94b44404/html5/thumbnails/12.jpg)
Research Participants
Research Participants
Sponsor
Advocates
IRB
Research Team
Institutions
Government Public
Family
Investigator
![Page 13: Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP Corporate Director Institutional Review Board Christiana Care.](https://reader034.fdocuments.in/reader034/viewer/2022042822/56649e4e5503460f94b44404/html5/thumbnails/13.jpg)
Compliance StakeholdersShared Responsibility
• Investigators/Research Team• Sponsors• Institutions• IRBs• Government • Private Sector
![Page 14: Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP Corporate Director Institutional Review Board Christiana Care.](https://reader034.fdocuments.in/reader034/viewer/2022042822/56649e4e5503460f94b44404/html5/thumbnails/14.jpg)
Private Sector Initiatives
• Certification of Individuals– investigators– research Coordinators– IRB key staff and members– key study personnel
• Accreditation of Programs – Institution
![Page 15: Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP Corporate Director Institutional Review Board Christiana Care.](https://reader034.fdocuments.in/reader034/viewer/2022042822/56649e4e5503460f94b44404/html5/thumbnails/15.jpg)
Health System Perspectives
• Primary focus is optimum patient care and outcomes
• Maintain economic viability in light of reduced reimbursements, increased competition and costs
• Reduce operating expenses and maximize revenues
• Retain and expand market share of key services
• Examine scope of services provided for potential realignment to meet strategic goals
• “Work smarter with less, to provide more, while maintaining positive patient outcomes and economic viability ”
![Page 16: Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP Corporate Director Institutional Review Board Christiana Care.](https://reader034.fdocuments.in/reader034/viewer/2022042822/56649e4e5503460f94b44404/html5/thumbnails/16.jpg)
Health System Initiatives
• Key strategy is recognition that compliance is a health system responsibility
• Compliance must be viewed as an integral component of the corporate culture
• Requires the active involvement of all departments and personnel
• Transcends all boundaries
• Executive Management and Board of Director’s support
• Recognition of the potential liabilities and costs of noncompliance
![Page 17: Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP Corporate Director Institutional Review Board Christiana Care.](https://reader034.fdocuments.in/reader034/viewer/2022042822/56649e4e5503460f94b44404/html5/thumbnails/17.jpg)
Health System Existing Resources
• Corporate Compliance• Accreditation and Performance Improvement• Research & Grants• Institutional Review Board• Executive Management • Laboratory, Radiology, Ancillary Departments• Medical Staff• Finance & Internal Audit• Information Services• HIMS• Organizational Development
![Page 18: Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP Corporate Director Institutional Review Board Christiana Care.](https://reader034.fdocuments.in/reader034/viewer/2022042822/56649e4e5503460f94b44404/html5/thumbnails/18.jpg)
Health System Initiatives
• Designation of a project leader
• Identification of the key stakeholders
• Preparation of a strategic plan or SWOT Analysis utilizing existing infrastructure and expertise
• Assignment of identified issues, required systems development and support, to an individual “champion”
• Formation of interdisciplinary workgroups to support each champion to provide practical solutions to achieving the assigned task with current resources
![Page 19: Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP Corporate Director Institutional Review Board Christiana Care.](https://reader034.fdocuments.in/reader034/viewer/2022042822/56649e4e5503460f94b44404/html5/thumbnails/19.jpg)
Health System Initiatives
• Clear, concise direction and tightly controlled time lines for each workgroup
• Open communication among working groups to assist in resolution of identified issues that may require expertise from one another
• Establish aggressive schedule for joint meetings of project champions to report on progress, issue identification and assistance that may be required to achieve assigned tasks
![Page 20: Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP Corporate Director Institutional Review Board Christiana Care.](https://reader034.fdocuments.in/reader034/viewer/2022042822/56649e4e5503460f94b44404/html5/thumbnails/20.jpg)
Health System Initiatives
• Develop an implementation plan with targeted milestones with emphasis on communication tactics to varied stakeholder audiences
• Identify key individuals to act as resources for each major area
• Establish in conjunction with the existing Health System Corporate Compliance Office, a formally recognized Committee to convene on a regularly scheduled basis to address new issues, develop methods of auditing compliance in the varying departments and establish a Continuous Process Improvement component
![Page 21: Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP Corporate Director Institutional Review Board Christiana Care.](https://reader034.fdocuments.in/reader034/viewer/2022042822/56649e4e5503460f94b44404/html5/thumbnails/21.jpg)
Summary
• Key strategy is recognition that compliance is a health system responsibility
• Compliance must be viewed as an integral component of the corporate culture
• Requires the active involvement of all departments and personnel
• Transcends all boundaries
• Executive Management and Board of Director’s support
• Recognition of the potential liabilities and costs of noncompliance
![Page 22: Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP Corporate Director Institutional Review Board Christiana Care.](https://reader034.fdocuments.in/reader034/viewer/2022042822/56649e4e5503460f94b44404/html5/thumbnails/22.jpg)
![Page 23: Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP Corporate Director Institutional Review Board Christiana Care.](https://reader034.fdocuments.in/reader034/viewer/2022042822/56649e4e5503460f94b44404/html5/thumbnails/23.jpg)